Our findings implicate SUMO-deficient phospho-PR-B in the selective regulation of genes that are important for breast cancer cell proliferation and are pro-survival, and suggest that phosphorylated and deSUMOylated PRs may be important drivers of the ERBB2+ phenotype associated with rapid (luminal) breast cancer tumor progression. The gene discussed is WNK3; the disease is breast cancer.